Abstract
Atopic eczema is a chronic, recurrent, multifactorial skin disease, and, accordingly, there are numerous therapeutic options for its symptomatic treatment. Conventional medications are however often unsatisfactory for many patients because of adverse effects on long-term use. For this reason, patients often readily welcome unconventional therapeutic approaches. We present here a selected number of such treatment modalities, namely γ-linolenic acid, Chinese herbal tea, diets eliminating allergens, pseudoallergens, metal salts and sodium, and bioresonance. When stringent scientific criteria are applied in the evaluation of such study results, none of the reviewed alternative treatments provides unequivocal, convincing evidence of its efficacy, even when double-blind, placebo-controlled studies are available. With Chinese herbal tea, potentially serious adverse effects should be considered as well. Any new type of unconventional therapy should thus be thoroughly evaluated and shown to be equal or superior to conventional treatments with regard to both efficacy and tolerability before it is recommended for use in clinical practice.
References
1.
Henz BM, Grabbe J: Das atopische Ekzem; in Wahn U, Seger R, Wahn V (eds): Pädiatrische Allergologie und Immunologie, ed 3. Stuttgart, Fischer, 1999, pp 320–327.
2.
Worm M, Henz BM: Molekulargenetische Grundlagen der Allergie: Ansätze für eine rationale Therapie; in Ganten D, Ruckpaul K (eds): Immunsystem und Infektiologie: Handbuch der molekularen Medizin. Berlin, Springer, 1999, pp 126–156.
3.
Oranje AP, Wolkerstorfer A: Advances in the treatment of atopic dermatitis with special regard to children. Curr Probl Dermatol 1999;28:56–63.
4.
Ruzicka T: Atopic eczema between rationality and irrationality. Arch Dermatol 1998;134:1462–1469.
5.
Van der Meer JB, Glazenburg EJ, Mulder PG, Eggink HF: The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. Br J Dermatol 1999;140:1115–1121.
6.
Naeyaert JM, Lachapelle JM, Degreef H, de la Brassine M: Cyclosporin in atopic dermatitis: Review of the literature and outline of a Belgian consensus. Dermatology 1999;198:145–152.
7.
Fischer G: Compliance problems in paediatric atopic eczema. Australas J Dermatol 1996;37(suppl):10–13.
8.
Hansen AE, Knott EM, Wiese HF, Shapermann E: Eczema and essential fatty acids. Am J Dis Child 1947;73:1–18.
9.
Santoli D, Phillips PD, Colt TL, Zurier RB: Suppression of interleukin-2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. J Clin Invest 1990;85:424–432.
10.
Berth-Jones J, Graham Brown RAC: Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet 1993;341:1557–1560.
11.
Soyland E, Funk J, Rajka G, Sandberg M: Dietary supplementation with very long-chain n–3 fatty acids in patients with atopic dermatitis: A double-blind, multicentre study. Br J Dermatol 1994;130:757–764.
12.
Borrek S, Hildebrandt A, Forster J: Gamma-linoleic-acid-rich borage seed oil capsules in children with atopic dermatitis: A placebo-controlled double-blind study. Klin Pädiatr 1997;209:100–104.
13.
Hederos CA, Berg A: Epogam evening primrose oil treatment in atopic dermatitis and asthma. Arch Dis Child 1996;75:494–497.
14.
Shield MJ, Wilson AM, Horrobin DF, Morse PF: Essential fatty acid supplementation in atopic dermatitis. Lancet 1993;342:377–378.
15.
Horrobin DF, Stewart C: Evening primrose oil and atopic eczema. Lancet 1990;336:50.
16.
Sharpe GR, Farr PM: Evening primrose oil and eczema. Lancet 1990;335:1283.
17.
Henz BM, Jablonska S, van de Kerkhof P, Stingl G: Double-blind, multicenter analysis of the efficacy of borage oil in patients with atopic eczema. Br J Dermatol 1999;140:685–688.
18.
Sheehan MP, Rustin MHA, Atherton DJ, Buckley C: Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis. Lancet 1992;340:13–17.
19.
Sheehan MP, Atherton DJ: A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema. Br J Dermatol 1992;340:13–17.
20.
Latchman Y, Whittle B, Rustin MHA, Atherton DJ: The efficacy of traditional Chinese herbal therapy in atopic eczema. Int Arch Allergy Immunol 1994;104:222–226.
21.
Koo J, Arain S: Traditional Chinese medicine for the treatment of dermatologic disorders. Arch Dermatol 1998;134:1388–1393.
22.
Perharic-Walton L, Murray V: Toxicity of Chinese herbal remedies. Lancet 1992;340:674.
23.
Ferguson JE, Chalmers RJ, Rowlands DJ: Reversible dilated cardiomyopathy following treatment of atopic eczema with Chinese herbal medicine. Br J Dermatol 1997;136:592–593.
24.
Sheehan MP, Atherton DJ: One year follow-up of children treated with Chinese medicinal herbs for atopic eczema. Br J Dermatol 1994;130:488–493.
25.
Sheehan MP, Stevens H, Osterele LSD, Atherton DJ: Follow-up of adult patients with atopic eczema treated with Chinese herbal therapy for one year. Clin Exp Dermatol 1995;20:136–140.
26.
Xu XJ, Banerjee P, Rustin MH, Poulter LW: Modulation by Chinese herbal therapy of immune mechanisms in the skin of patients with atopic eczema. Br J Dermatol 1997;136:54–59.
27.
Latchman Y, Banerjee P, Poulter LW, Rustin M: Association of immunological changes with clinical efficacy in atopic eczema patients treated with traditional Chinese herbal therapy (Zemaphyte). Int Arch Allergy Immunol 1996;109:243–249.
28.
Banerjee P, Xu X, Poulter LW, Rustin MH: Changes in CD23 expression of blood and skin in atopic eczema after Chinese herbal therapy. Clin Exp Allergy 1998;28:306–314.
29.
Fung AY, Look PC, Chong LY, But PP: A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis. Int J Dermatol 1999;38:387–392.
30.
Latchman Y, Bungy GA, Atherton DJ, Rustin MH: Efficacy of traditional Chinese herbal therapy in vitro. A model system for atopic eczema: Inhibition of CD23 expression on blood monocytes. Br J Dermatol 1995;132:592–598.
31.
Edwards CRW: Lessons from licorice. N Engl J Med 1991;325:1223–1227.
32.
Sampson HA: Atopic dermatitis. Ann Allergy 1991;69:469–482.
33.
Niggemann B, Sampson HA, Wahn U: Proposals for standardization of oral food challenge tests in infants and children. Pediatr Allergy Immunol 1994;5:11–13.
34.
Halken S, Jacobson HP, Host A, Holmenlund D: The effect of hypo-allergenic formulas in infants at risk of allergic disease. Eur J Clin Nutr 1995;49(suppl 1):77–83.
35.
Resano A, Crespo E, Fernandez-Benitez M, Sanz ML: Atopic dermatitis and food allergy. J Invest Allergol Clin Immunol 1998;8:271–276.
36.
Zuberbier T, Chantraine-Hess S, Hartmann K, Czarnetzki BM: Pseudoallergen-free diet in the treatment of chronic urticaria. Acta Derm Venereol (Stockh) 1995;75:484–487.
37.
Gutgesell C, Schäkel K, Fuchs T, Neumann C: Nahrungsmitteladditiva sind kein Schubfaktor der atopischen Dermatitis bei Erwachsenen. Allergologie 1997;20:519–521.
38.
Worm M, Ehlers I, Sterry W, Zuberbier T: Clinical relevance of food additives in adult patients with atopic dermatitis. Clin Exp Allergy, in press.
39.
Adachi A, Horikawa T, Takashima T, Komura T: Potential efficacy of low metal diets and dental metal elimination in the management of atopic dermatitis: An open clinical study. J Dermatol 1997;24:12–19.
40.
Barthel HR, Stuhlmuller B: Improvement in atopic dermatitis with change to low-salt table water. Lancet 1994;344:1089.
41.
Dupuy P, Casse M, André F, Dhivert-Donnadieu H: Low-salt water reduces intestinal permeability in atopic patients. Dermatology 1999;198:153–155.
42.
Schumacher P: Biophysikalische Therapie der Allergien: Erweiterte Bioresonanztherapie. Stuttgart, Sonntag, 1994.
43.
Schoni MH, Nikolaizik WH, Schoni-Affolter F: Efficacy trial of bioresonance in children with atopic dermatitis. Int Arch Allergy Immunol 1997;112:238–246.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
